Pricing Log in Create free account

Medpace Holdings, Inc. (MEDP) vs QIAGEN N.V. (QGEN)

Medpace Holdings, Inc. and QIAGEN N.V. are both Diagnostics & Research companies. Medpace Holdings, Inc. is the larger, with a market value of $17.6B against $9.5B — 1.8× the size. QIAGEN N.V. trades at the lower P/E: 23.6× against 35.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 24.7% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 17.7%) and the higher return on invested capital (6.62% vs 0.00%). Across the 22 metrics below, QIAGEN N.V. leads on 13 and Medpace Holdings, Inc. on 9.

Valuation

Metric MEDP QGEN Diagnostics & Research median
P/E 35.56 23.64 35.56
P/S 6.26 4.53 4.37
P/B 40.16 2.83 3.06
Price to free cash flow 24.66 21.60 35.76
EV/EBITDA 27.87 15.93 24.35
EV/Sales 6.12 4.94 5.51
Earnings yield 2.81% 4.23% (1.89%)
Free cash flow yield 4.06% 4.63% (0.15%)

Profitability

Metric MEDP QGEN Diagnostics & Research median
Gross margin 72.35% 62.20% 50.89%
Operating margin 20.97% 21.21% (8.57%)
Net margin 17.67% 19.49% (6.37%)
Free cash flow margin 25.40% 20.98% 0.00%
Return on equity 162.15% 11.93% (2.92%)
Return on assets 27.09% 6.99% (6.71%)
Return on invested capital 0.00% 6.62% 0.00%

Growth

Metric MEDP QGEN Diagnostics & Research median
Revenue growth (TTM) 24.67% 2.96% 7.69%
EPS growth (last fiscal year) 20.98% 398.07% 25.92%
Revenue growth, 5-year CAGR 22.27% 2.25% 7.40%
Net income growth, 5-year CAGR 25.50% 3.42% 0.00%

Health

Metric MEDP QGEN Diagnostics & Research median
Debt to equity 0.00 0.49 0.11
Current ratio 0.73 2.85 2.02
Net debt to EBITDA (0.88) 0.84 0.70

Dividend

Metric MEDP QGEN Diagnostics & Research median
Dividend yield — 0.76% 0.66%
Payout ratio — 0.18 0.20

Size

Metric MEDP QGEN Diagnostics & Research median
Market cap 17.55b 9.51b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack